{"id":19497,"date":"2021-05-12T16:23:30","date_gmt":"2021-05-12T10:53:30","guid":{"rendered":"http:\/\/udaen.info\/?p=19497"},"modified":"2021-05-12T16:23:30","modified_gmt":"2021-05-12T10:53:30","slug":"pibs-bulletin-on-covid-19-3","status":"publish","type":"post","link":"https:\/\/udaen.info\/?p=19497","title":{"rendered":"PIB\u2019S BULLETIN ON COVID-19"},"content":{"rendered":"<p style=\"font-weight: 400;\">PIB Headquarters<\/p>\n<h2 style=\"font-weight: 500;\">PIB\u2019S BULLETIN ON COVID-19<\/h2>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<table style=\"font-weight: 400;\">\n<tbody>\n<tr>\n<td>&nbsp;<\/p>\n<ul>\n<li><b><strong>India\u2019s Active Caseload Declines for the Second Consecutive day<\/strong><\/b><\/li>\n<li><b><strong>WHO has not associated the term \u201cIndian Variant\u201d with B.1.617, now classified as Variant of Concern<\/strong><\/b><\/li>\n<li><b><strong>Government to ramp up availability of Amphotericin B &#8211; to fight Mucormycosis<\/strong><\/b><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 style=\"font-weight: 500;\"><\/h2>\n<h2 style=\"font-weight: 500;\"><\/h2>\n<h2 style=\"font-weight: 500;\"><\/h2>\n<h2 style=\"font-weight: 500;\"><\/h2>\n<h2 style=\"font-weight: 500;\">#Unite2FightCorona<\/h2>\n<h2 style=\"font-weight: 500;\">#IndiaFightsCorona<\/h2>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<h2 style=\"font-weight: 500;\">PRESS INFORMATION BUREAU<\/h2>\n<h2 style=\"font-weight: 500;\">MINISTRY OF INFORMATION AND BROADCASTING<\/h2>\n<h2 style=\"font-weight: 500;\">GOVERNMENT OF INDIA<\/h2>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\"><b><strong><u>India\u2019s Active Caseload Declines for the Second Consecutive day<\/u><\/strong><\/b><\/p>\n<p style=\"font-weight: 400;\">\n<ul style=\"font-weight: 400;\">\n<li>New Recoveries outnumber Daily New COVID Cases for the Second Consecutive day<\/li>\n<li>India\u2019s Cumulative Vaccination Coverage exceeds 17.5 Crore<\/li>\n<li>More than 30 lakh beneficiaries of age group 18-44 Vaccinated so far<\/li>\n<li>The National Recovery Rate\u00a0is 83.04%.<\/li>\n<li>The National Mortality Rate currently stands at 1.09%.<\/li>\n<\/ul>\n<p style=\"font-weight: 400;\">For details:\u00a0<a href=\"https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717870\">https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717870<\/a><\/p>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\"><b><strong><u>WHO has not associated the term \u201cIndian Variant\u201d with B.1.617, now classified as Variant of Concern<\/u><\/strong><\/b><\/p>\n<p style=\"font-weight: 400;\">This is to clarify that WHO has not associated the term \u201cIndian Variant\u201d with the B.1.617 variant of the coronavirus in its 32 page document.<\/p>\n<p style=\"font-weight: 400;\">For Details<b><strong><u>\u00a0:<\/u><\/strong><\/b><a href=\"https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717876\"><b><strong>https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717876<\/strong><\/b><\/a><\/p>\n<p style=\"font-weight: 400;\">\n<b><strong><u>Ministry of Power takes proactive measures to ensure 24&#215;7 power supply to Oxygen Power Plants in the Country<\/u><\/strong><\/b><\/p>\n<p style=\"font-weight: 400;\">In view of the pan India impact of the second wave of corona virus pandemic across the country and the manifold rise in oxygen demand for both medical facilities and for home treatment of patients , the Ministry of Power has undertaken a number of pro-active preventive and remedial measures to ensure that there is uninterrupted power supply to Oxygen Plants by the State Utilities<\/p>\n<p style=\"font-weight: 400;\"><b><strong><u>For Details:\u00a0<\/u><\/strong><\/b><a href=\"https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717861\"><b><strong>https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717861<\/strong><\/b><\/a><\/p>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\"><b><strong><u>Government take steps to ramp up availability of Amphotericin B &#8211; to fight Mucormycosis<\/u><\/strong><\/b><br \/>\nA sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post COVID complication. The Government of India is therefore engaging with the manufacturers to ramp up production of the drug. The supply position is expected to improve with extra imports of this drug and increase in its production domestically.<\/p>\n<p style=\"font-weight: 400;\"><b><strong><u>For Details:\u00a0<\/u><\/strong><\/b><a href=\"https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717864\"><b><strong>https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1717864<\/strong><\/b><\/a><\/p>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\"><b><strong><u>PIB FACT CHECK<\/u><\/strong><\/b><\/p>\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n<p style=\"font-weight: 400;\">\n","protected":false},"excerpt":{"rendered":"<p>PIB Headquarters PIB\u2019S BULLETIN ON COVID-19 &nbsp; India\u2019s Active Caseload Declines for the Second Consecutive day WHO has not associated the term \u201cIndian Variant\u201d with B.1.617, now classified as Variant of Concern Government to ramp up availability of Amphotericin B &#8211; to fight Mucormycosis #Unite2FightCorona #IndiaFightsCorona PRESS INFORMATION BUREAU MINISTRY OF INFORMATION AND BROADCASTING GOVERNMENT [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[74],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/19497"}],"collection":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19497"}],"version-history":[{"count":1,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/19497\/revisions"}],"predecessor-version":[{"id":19498,"href":"https:\/\/udaen.info\/index.php?rest_route=\/wp\/v2\/posts\/19497\/revisions\/19498"}],"wp:attachment":[{"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udaen.info\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}